Booth #304
175 Crossing Blvd.
Framingham, MA 01702
Telephone: (508) 620-9700
Website: www.revobiologics.com
rEVO Biologics Inc. (www.revobiologics.com) is a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. The company’s lead product, ATryn, is the first and only plasma-free antithrombin concentrate. ATryn received FDA approval in 2009.
